Whether or not the use of proton pump inhibitors (PPIs) leads to the development of Clostridium difficile (C. diff) infection has been an ongoing question. A recent article in Pharmacotherapy studied this question in a retrospective, single-center, cohort study of over 41,000 patients. These authors found an association between the use of at least one dose of a PPI and both the rate and severity of hospital-acquired C. diff infection. Do you agree? Have you found that patients at your institution who have received PPIs are more likely to develop C. diff infection? Please comment.
Comprehensive Pharmacy Services, Inc. All Rights Reserved. The CPS and the CPS logo are trademarks of Comprehensive Pharmacy Services, Inc. All other product names are trademarks, registered trademarks, or service marks of their respective owners.